BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

DAVIDSON KEMPNER CAPITAL MANAGEMENT LP's Holding History (CIK: 0001595082)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 10,000,000 Value ($000) $11,225 Avg Close — Range —
Q3 2025
Shares 30,000,000 Value ($000) $29,535 Avg Close — Range —
Q2 2025
Shares 30,000,000 Value ($000) $27,930 Avg Close — Range —
Q1 2025
Shares 30,000,000 Value ($000) $26,895 Avg Close — Range —
Q4 2024
Shares 25,000,000 Value ($000) $21,325 Avg Close — Range —